​

PDS Bio (PDSB) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

PDSB Stock Forecast

PDS Bio (PDSB) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $9.00 and a low of $9.00. This represents a 402.79% increase from the last price of $1.79.

$1 $2 $3 $4 $5 $6 $7 $8 $9 High: $9 Avg: $9 Low: $9 Last Closed Price: $1.79

PDSB Stock Rating

PDS Bio stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

PDSB Price Target Upside V Benchmarks

TypeNameUpside
StockPDS Bio402.79%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.79$1.79$1.79
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2512---3
May, 2512---3
Apr, 2513---4
Mar, 2513---4
Feb, 2514---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 12, 2024Mayank MamtaniB.Riley Financial$9.00$2.76226.09%402.79%
Mar 28, 2024Mayank MamtaniB.Riley Financial$11.00$3.85185.71%514.53%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 27, 2025H.C. WainwrightBuyBuyhold
Nov 14, 2024Alliance Global PartnersBuyBuyhold
Oct 03, 2024H.C. WainwrightBuyBuyhold
Aug 20, 2024Alliance Global PartnersBuyBuyhold
Mar 28, 2024Alliance Global PartnersBuyBuyhold
Nov 15, 2022Chardan CapitalBuyBuyhold
May 13, 2022Alliance Global PartnersBuyBuyhold

Financial Forecast

EPS Forecast

$-2K $-1K $-900 $-600 $-300 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.39$-1.08K----
Avg Forecast$-1.46$-1.22$-1.22$-1.25$-1.49$-1.51
High Forecast$-1.42$-1.13$-1.04$-1.15$-1.45$-1.51
Low Forecast$-1.53$-1.40$-1.40$-1.37$-1.52$-1.51
Surprise %-4.79%88379.51%----

Revenue Forecast

$0 $5M $10M $15M $20M $25M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$366.67K$11.25M$23.15M$3.80M
High Forecast--$366.67K$11.25M$23.15M$3.80M
Low Forecast--$366.67K$11.25M$23.15M$3.80M
Surprise %------

Net Income Forecast

$-40B $-32B $-24B $-16B $-8B $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-42.94M$-39.35B----
Avg Forecast$-45.57M$-40.56M$-37.72M$-39.00M$-45.96M$-46.74M
High Forecast$-43.84M$-34.86M$-32.26M$-35.59M$-44.88M$-46.74M
Low Forecast$-47.31M$-43.34M$-43.19M$-42.40M$-47.05M$-46.74M
Surprise %-5.78%96922.59%----

PDSB Forecast FAQ

Is PDS Bio stock a buy?

PDS Bio stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that PDS Bio is a favorable investment for most analysts.

What is PDS Bio's price target?

PDS Bio's price target, set by 7 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $9 at the low end to $9 at the high end, suggesting a potential 402.79% change from the previous closing price of $1.79.

How does PDS Bio stock forecast compare to its benchmarks?

PDS Bio's stock forecast shows a 402.79% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for PDS Bio over the past three months?

  • June 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is PDS Bio’s EPS forecast?

PDS Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.22, marking a -99.89% decrease from the reported $-1.079K in 2024. Estimates for the following years are $-1.25 in 2026, $-1.49 in 2027, and $-1.51 in 2028.

What is PDS Bio’s revenue forecast?

PDS Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $366.67K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $11.25M, followed by $23.15M for 2027, and $3.8M for 2028.

What is PDS Bio’s net income forecast?

PDS Bio's net income forecast for the fiscal year ending in December 2025 stands at $-37.724M, representing a -99.90% decrease from the reported $-39.349B in 2024. Projections indicate $-39M in 2026, $-45.964M in 2027, and $-46.738M in 2028.